Corgi | $108,000,000 | (Jan 9, 2026)
Corsera Health | $80,000,000 | (Jan 9, 2026)
Oasys | $4,600,000 | (Jan 9, 2026)
Certified by Founder
Lodge
I2BF Global Ventures
investor
United States
- New York, NY
- 13/12/2022
- Series A
- $21,000,000
I2BF Global Ventures is a New York based venture capital group focused on early stage technology investments with $400 million under management. I2BF’s portfolio includes over 30 companies working in cleantech, biotechnology, materials science, IT and space technology sectors.
- Industry Venture Capital and Private Equity Principals
- Website https://www.i2bf.com/
- LinkedIn https://www.linkedin.com/company/i2bf-global-ventures/
Related People
Ilya GolubovichFounder
United States -
New York, NY
Ilya Golubovich is the founding and managing partner of I2BF Global Ventures, an international venture capital group focused on early stage technology investments with over $500 million under management. I2BF’s portfolio includes over 100 companies working in frontier tech, digital transformation and future of content industries.
Vizgen | $48,000,000 | (Jan 9, 2026)
Poplar Therapeutics | $50,000,000 | (Jan 9, 2026)
Carna Health | $8,000,000 | (Jan 9, 2026)
Valinor(US) | $54,000,000 | (Jan 9, 2026)
Alveus Therapeutics Inc | $160,000,000 | (Jan 9, 2026)
AgileRL | $7,500,000 | (Jan 9, 2026)
Soley Therapeutics | $200,000,000 | (Jan 9, 2026)
EpiBiologics | $107,000,000 | (Jan 9, 2026)
SpangleAI | $15,000,000 | (Jan 9, 2026)
Presto Phoenix, Inc. | $10,000,000 | (Jan 9, 2026)